Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the government-funding operating-status notice.SummaryDifference0.5%

- Check21 days agoChange DetectedA new system notice informs users about government funding lapse and the NIH Clinical Center's status. The revision history shows version v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedUI updates add a glossary display option and new metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a footer note (No FEAR Act Data) and a site revision indicator (v3.4.0), replacing the previous v3.3.4.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section listing Louisville, Kentucky as the study site; removed the Kentucky Locations entry and HHS Vulnerability Disclosure; updated the page revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing the prior v3.2.0; this is a minor UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.